Yatırımcı.AI

ECILC vs TEZOL Comparison

Price, market cap, valuation, profitability and leverage metrics of ECILC and TEZOL side by side.

ECILCTEZOL
StockFund

If You Had Invested TRY 10,000

Metric Comparison

ECILC vs TEZOL Comparison
MetricECILCTEZOLSector median
Last price (TL)63.607.1118.72
Daily change−7.15%−4.56%−5.57%
Market capTRY 43.6BTRY 3.6BTRY 4.3B
P/B0.680.551.09
Dividend yield2.04%2.36%0.90%
Return on equity−3.08%−0.66%1.78%
Free float22.02%23.80%37.21%
Ratios are calculated from the latest published financial statements.

Popular Comparisons

Related Pages

About the ECILC vs TEZOL Comparison

Price, market cap, valuation multiples, profitability and leverage of ECILC (Eczacıbaşı İlaç) and TEZOL (Europap Tezol Kağıt) side by side as of Sep 28, 2026, 13:42. Of the 14 metrics compared, ECILC leads in 2 and TEZOL leads in 12.

Highlights: Daily change: TEZOL leads (−4.56% vs −7.15%). Market cap: ECILC leads (TRY 43.6B vs TRY 3.6B). P/B: TEZOL leads (0.55 vs 0.68). EV/EBITDA: TEZOL leads (10.93 vs 165.19). EV/Sales: TEZOL leads (0.88 vs 9.35). Dividend yield: TEZOL leads (2.36% vs 2.04%). Gross margin: ECILC leads (37.83% vs 9.07%). EBITDA margin (annual): TEZOL leads (1,093.10% vs 11.49%).

Frequently Asked Questions

By P/E, Tie is cheaper (— vs —); by P/B, TEZOL trades at the lower multiple (0.68 vs 0.55).

Annual net margin is −20.86% for ECILC and −0.82% for TEZOL; return on equity is −3.08% for ECILC and −0.66% for TEZOL.

The leverage ratio is 18.92 for ECILC and 16.43 for TEZOL; net debt/EBITDA is 1.37 for ECILC and — for TEZOL. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.